Maternal Perinatal Depressive Symptoms, Prenatal Maternal Selective Serotonin Reuptake Inhibitor Antidepressants, and
Sarah M Hutchison1, Ursula Brain1, Ruth E Grunau1
1Department of Pediatrics, University of British Columbia and BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Insights
Maternal depression during pregnancy, not SSRI exposure, impacts child executive functions (EFs) long-term. Addressing maternal mental health is crucial for children's development.
Area of Science:
- Neuroscience
- Developmental Psychology
- Psychiatry
Background:
- Maternal mental health during pregnancy is critical for offspring neurodevelopment.
- Selective serotonin reuptake inhibitor (SSRI) exposure in utero is a concern for developmental outcomes.
- Executive functions (EFs) are vital cognitive skills for academic and social success.
Purpose of the Study:
- To investigate the association between maternal depressive symptoms and prenatal SSRI exposure with offspring executive functions (EFs) at ages 6 and 12.
- To differentiate the impact of maternal depression versus SSRI treatment on child cognitive development.
Main Methods:
- Prospective cohort study of 191 mother-child pairs.
- Longitudinal assessment of maternal depressive symptoms from pregnancy to 12 years postpartum.
- Measurement of offspring EFs using computer-based tasks and parent-report questionnaires (BRIEF) at ages 6 and 12.
Main Results:
- Children demonstrated improved performance on EF tasks with age.
- Fewer maternal prenatal depressive symptoms correlated with better child accuracy on specific EF tasks and overall EF skills.
- Prenatal SSRI exposure was associated with more executive dysfunction at age 12, but this effect diminished when maternal depressive symptoms were controlled.
Conclusions:
- Maternal depressive symptoms, both prenatal and later, appear to be a significant factor influencing offspring executive functions into preadolescence.
- Prenatal SSRI exposure's impact on EFs is likely confounded by maternal depressive symptoms.
- Long-term maternal mental health support is essential for optimizing children's executive function development and overall life success.
Objective:
To determine whether mothers' depressive symptoms with or without exposure to selective serotonin reuptake inhibitor (SSRI) antidepressant treatments during pregnancy were associated with executive functions (EFs) in offspring at 6 and 12 years of age.
Methods:
A prospective cohort of 191 mothers and their children participated in the study. Clinician-rated reports of mothers' depressive symptoms were obtained spanning the third trimester during pregnancy to 12 years later. Children's EFs were measured using 2 computer-based tasks (Flanker/Reverse Flanker, Hearts and Flowers [HF]) and mothers' reports of EFs using the Behavior Rating Inventory of Executive Function (BRIEF) when the child was 6 and 12 years old.
Results:
Longitudinal analyses showed that all children were both faster and more accurate on both Flanker/Reverse Flanker and HF with age. Fewer maternal prenatal depressive symptoms were associated with better accuracy on HF in children at 6 years of age and better EF skills as measured by the BRIEF at 6 and 12 years. Mothers' ratings of their children at 12 years indicated more executive dysfunction in children with prenatal SSRI exposure than for children without prenatal SSRI exposure, but this was no longer significant once prenatal depressive symptoms were taken into account.
Conclusion:
Prenatal and later depressive symptoms, not prenatal SSRI exposure, seems to affect offspring that continues into preadolescence, highlighting the importance of long-term mental health follow-up in mothers to ensure optimal development of children's EFs and hence their optimal development in school, in social relations, and in life generally.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
01:30Socioemotional Development during Infancy
Primary Temperament Types
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
01:25Antidepressant Drugs: Overview
01:27Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...